Stay updated with breaking news from Daptorum Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group", the "Company"), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to address global
These Hot Penny Stocks Continue to Spike As a Result of Reddit Traders Reddit penny stocks have become some of the hottest trending penny stocks to watch over the last year. If youâre unfamiliar, Reddit is a social media platform that allows individuals to form groups or Subreddits. These Subreddits are based on anything from cats to old cars and you guessed it, penny stocks. Popular investor Subreddits include the likes of r/WallStreetBets and r/RedditPennyStocks among others. And while this may not have had a major effect on actual trading in the past, it is now a major factor to ...
Aptorum Group Limited to Present at The Benzinga Global Small Cap Conference Regulatory News: Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced that Mr. Darren Lui, President and Executive Director of Aptorum Group, will present at the Benzinga Global Small Cap Conference. The Benzinga Global Small Cap Conference Date: Friday, May 14, 2021 Time: 5:05 PM Eastern Time (2:05 PM Pacific Time) To attend the presentation, please...
Aptorum Group Limited Interview to Air on Bloomberg Television U.S. on the RedChip Money Report Regulatory News: Aptorum Group Limited (Nasdaq: APM), a clinical-stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology and infectious diseases, today announced an interview with President and Executive Director, Mr. Darren Lui, will air on The RedChip Money Report on the Bloomberg Network in the U.S. on Saturday, April 24 at 7 p.m. local time across the United States. The RedChip Money Report airs on Bloomberg Television U.S. on Saturdays at 7 p.m. local time in 73M h...
(0) Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) ("Aptorum Group" or "Aptorum"), a clinical-stage biopharmaceutical company, through its affiliate, has entered into a material transfer and option agreement ("Agreement") with Yale University ("Yale") to evaluate a group of preclinical stage novel immunomodulators. The novel immunomodulators may potentially target autoimmune and oncology diseases, including but not limited to, rheumatoid arthritis, lupus and sclerosis, as well as a variety of cancers, all subject to further preclinical development and testing. Aptor...